Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. - Wikidata - awgldk - TriplyDB

Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

http://www.wikidata.org/entity/Q43225292

about

Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.T cell-mediated host immune defenses in the lung A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients Inflammatory monocytes orchestrate innate antifungal immunity in the lung.Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series.Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.NADPH oxidase regulates efficacy of vaccination in aspergillosis Suppression of epithelial signal transducer and activator of transcription 1 activation by extracts of Aspergillus fumigatus.C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America.Innate antifungal immunity: the key role of phagocytes.Cracking the Toll-like receptor code in fungal infections.T-cell Subsets and Antifungal Host Defenses Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.T cell immunity and vaccines against invasive fungal diseases.Cytokines and the regulation of fungus-specific CD4 T cell differentiation.Immunotherapy against invasive mold infections.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Minireview: host defence in invasive aspergillosis.The innate immune response to Aspergillus fumigatus at the alveolar surface.Caspofungin Increases Fungal Chitin and Eosinophil and γδ T Cell-Dependent Pathology in Invasive Aspergillosis.LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus.Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions?Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies.Co-recognition of β-glucan and chitin and programming of adaptive immunity to Aspergillus fumigatus.Toll-like receptor 2 induced cytotoxic T-lymphocyte-associated protein 4 regulates Aspergillus-induced regulatory T-cells with pro-inflammatory characteristics.Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.Fungal Pathogens in CF Airways: Leave or Treat?Impairment of Immune Response against Dematiaceous Fungi in Card9 Knockout Mice.Aspergillus fumigatus morphology and dynamic host interactions.Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals.Enhancement of anti-Aspergillus T helper type 1 response by interferon-β-conditioned dendritic cells.Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally Mimicking Aspergillus Galactomannan.Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi.Inflammation in aspergillosis: the good, the bad, and the therapeutic.Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients.

P2860

Q26864717-DA459ACF-60CD-4462-B5E3-5BEF95A03197 Q27312010-206AABE5-D884-4A73-8646-332868AD0D5D Q27932755-0E8CB523-003F-4BFE-9800-14AA774EDE98 Q28395374-60B0A563-D508-4F88-8F65-DB2CED67C5DB Q28540595-C16A16EA-0320-430A-A993-EADF0CED5EC2 Q33828598-0FCB0B88-8C07-4D78-B1FA-982F3CEA3DE7 Q34984670-2C4D27B3-7924-43F9-A29D-4568F312D2BB Q35105630-E5649CDA-6436-47D3-9197-58D4E1A5920A Q35131761-23571D08-6AF7-4156-BB95-99F30491B653 Q35591125-CCDC7932-412E-4C06-AA37-8DF51C3B2DD3 Q35913715-9BC8E966-A27C-4F12-AECD-E13A3CD93DFE Q35913774-28FCF6E4-6396-4F8A-8A74-82315FD64675 Q36049495-D6A2C7DC-8C24-439F-876B-24733D262C3F Q37543013-C83ABDB3-8B60-4AE1-87A2-7EE23BDC3BF5 Q37799378-12CE6A8E-2DFB-4897-A421-8C14F6585C6E Q37800920-089636EE-0218-41EF-9B41-9A8E1C47FC2F Q37803134-D46F9121-4F58-4EDA-8C78-FB2AD2E3B572 Q37821488-D24D2C84-73C6-43F4-A357-3A79A98200CB Q37911513-FA0EA3F6-03FD-49E3-A0CF-F7CD3E7E59EE Q37963574-B09845A3-117C-4F20-92AE-5BB3F5A2CAF0 Q37965757-61330C06-4101-4E5C-89BA-CBE1F8A39D8D Q38067451-E4282E9B-AD35-4856-AA16-00B78278E164 Q38081230-1817473B-CE14-4C3D-9F42-95FE3EE7CF18 Q38454116-5D5A96FD-2783-4863-AD72-52CAC12F94AE Q38676508-652D73A3-FDEA-4FA4-893C-1E8A47F93194 Q38835840-5C56038E-C28F-4FC0-AF68-8A3E883FCA79 Q38948097-DAB1CCC5-64D2-49D3-9F63-7ACB653219B0 Q38968506-765B7D40-6DA2-41DB-B527-C8F5A7685CD9 Q39009509-26E8A191-5234-4A7D-A16F-E39BD4CFA0A6 Q40047847-04013A6E-CA9C-4135-9C80-2B0E53961B17 Q40064394-3948F40C-C33E-40F7-8EBC-013D0123813C Q40108783-B5EBE813-0631-4394-BC94-90FF36AE0157 Q40611860-0C3DFD10-3FDE-4287-93C6-9BE79FAA836F Q41997165-973A6E61-9760-4150-A426-B347522E5628 Q42261981-208A2A14-8316-4E30-AB66-6EA1FF9C6B09 Q42662541-34B85CAE-BA39-41A5-98B0-2BA2D87277B8 Q42683287-C4DBBB9B-ACE2-4BD7-84E4-2CE68ECD6A93 Q43733156-74216C0E-12C0-428A-B919-E36E175E5649 Q44902285-FEFFB262-80F4-43D6-B916-CA3083213522 Q47314392-EEC2EE80-31D0-4294-8628-C81DC28B7B3A

P2860

Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

http://www.wikidata.org/entity/Q43225292

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Anti-Aspergillus human host de ...... per (Th17), cellular immunity.

@en

Anti-Aspergillus human host de ...... per (Th17), cellular immunity.

@nl

type

label

Anti-Aspergillus human host de ...... per (Th17), cellular immunity.

@en

Anti-Aspergillus human host de ...... per (Th17), cellular immunity.

@nl

prefLabel

Anti-Aspergillus human host de ...... per (Th17), cellular immunity.

@en

Anti-Aspergillus human host de ...... per (Th17), cellular immunity.

@nl

P1433

Q43225292-32B6AFC0-63AF-4846-869E-E2038BCE87D4

P1476

Q43225292-DE467860-837A-4883-BC40-7A674DF92A74

P2093

Q43225292-22A648B5-8A03-41AD-9824-E13AAA8FE72C

Q43225292-2E964BB5-3EBC-45C6-9BD1-CA18ED18F041

Q43225292-5F6A3971-F0D4-473F-A779-E1298B9EAACD

Q43225292-7820F915-EAD6-4C29-B485-D2228E9F1C77

Q43225292-82F48E0F-E922-4776-9CAE-A253B080EAEA

Q43225292-9F485E4C-7FE8-467C-AC39-336117C3BB86

Q43225292-A20065EB-F7BA-4401-9F5D-2AFF4031161E

Q43225292-CDBC0492-E83E-48BB-BAF6-E96CABD3C596

Q43225292-DA60B572-39DE-4659-BE9E-8F5EF5469DA3

Q43225292-E0AD9F46-CB55-40B6-9D8A-22FEC55559AB

P2860

Q43225292-005537DD-3B0F-4DE0-955A-132C2F487F7F

Q43225292-0933B123-2357-4969-830B-3DB3780FBBF5

Q43225292-0A827F0C-3CD2-4DEB-AFA6-9E17E0831E04

Q43225292-0B371152-6F85-42D8-805B-7F7150FCDE0C

Q43225292-117DD21D-14EF-49ED-BD7A-9337A1CC5EAE

Q43225292-12D22BFD-F2A8-40C7-80C4-F91B996B029D

Q43225292-1915879B-DD40-4C4B-ADB6-6AEF5ED363CF

Q43225292-1DA53F72-7351-4FA1-955D-55524D882D60

Q43225292-20664BF1-4D22-4CA4-9322-9FF23AE6F7C4

Q43225292-24BD4B65-DBE1-4D8F-A21E-54950CAE9748

P304

Q43225292-7CE234B4-45C3-4896-8523-87B4248B1B8D

P31

Q43225292-F33A5A78-BA9A-4FC3-B3E5-D8328A573DDE

P356

Q43225292-E88E4F1E-4289-4157-BD6E-BB40DCC6469D

P433

Q43225292-A210B99C-92B1-482E-9D18-2FD77F19F8CE

P478

Q43225292-F1742762-D532-4666-9AAD-5728E880F384

P50

Q43225292-275B67B7-2E75-4564-9479-72000CF9CC89

Q43225292-7629F9F3-FFEF-4EE1-8C0E-E1A9F326D265

P577

Q43225292-3EE8CAA8-2F0B-4B24-A98F-8B48BB995609

P5875

Q43225292-F53C759C-1085-4F3F-A315-76D2F9C3E2D4

P698

Q43225292-964A5296-6598-4FBF-BEB3-816E75AC7B17

P932

Q43225292-44CB6161-ACFC-4986-A619-88F77264E05E

P356

J.1365-2567.2009.03211.X

P1433

P1476

Anti-Aspergillus human host de ...... lper (Th17), cellular immunity

@en

P2093

Ai Leng Khoo

http://www.w3.org/2001/XMLSchema#string

Alieke G Vonk

http://www.w3.org/2001/XMLSchema#string

Bart-Jan Kullberg

http://www.w3.org/2001/XMLSchema#string

Frank van de Veerdonk

http://www.w3.org/2001/XMLSchema#string

Johan Maertens

http://www.w3.org/2001/XMLSchema#string

Katrien Lagrou

http://www.w3.org/2001/XMLSchema#string

Leo A B Joosten

http://www.w3.org/2001/XMLSchema#string

Louis Y A Chai

http://www.w3.org/2001/XMLSchema#string

Magda Hectors

http://www.w3.org/2001/XMLSchema#string

Mihai G Netea

http://www.w3.org/2001/XMLSchema#string

P2860

The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

STAT3 mutations in the hyper-IgE syndrome

TH17 cells in development: an updated view of their molecular identity and genetic programming

Interleukin-17 family members and inflammation

Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Development, cytokine profile and function of human interleukin 17-producing helper T cells

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

Immunity to Candida albicans: Th1, Th2 cells and beyond.

P304

46-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2567.2009.03211.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Shih-Chin Cheng

Renoud J Marijnissen

P577

2009-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40680666

http://www.w3.org/2001/XMLSchema#string

P698

20002791

http://www.w3.org/2001/XMLSchema#string

P932

2855792

http://www.w3.org/2001/XMLSchema#string